Category Archives: Health
Latest From Health
In today’s Morning Consult, the Community Oncology Alliance’s Rose Gerber has an excellent piece detailing the potential harm to patients posed by the Medicare Part B demonstration proposed by CMS last month: For Medicare patients, the impacts of CMS’s experiment could be dire. Reducing reimbursement to patients’ physicians to the level proposed would make it impossible for many providers to offer the most clinically effective treatment options to patients – forcing patients to forego prescribed Read More >
Anyone who has ever attended the BIO International Convention can attest to the intensity and excitement of the nearly weeklong event. The Convention is buzzing with partnering, networking and discovery, providing multiple opportunities for engagement at every level. Held in San Francisco from June 6-9, 2016, this year’s Convention promises the same standards of high-level programming. Two companies will earn the coveted title of “Buzz of BIO” through a contest that opens today! “Buzz of Read More >
BIO supports policy changes that protect patients’ ability to obtain access to the prescription drugs they need including policies that bolster enforcement of existing nondiscrimination requirement to ensure patients with high-cost health conditions are not penalized. A recent assessment of 2016 Qualified Health Plans in the Exchange Marketplace in 14 states, conducted by Harvard’s Center for Health Law and Policy Innovation (CHLPI), raises significant concerns, noting “there is increasing evidence that some QHPs are structured Read More >
In the United States, 1 in 9 Americans has kidney disease, and most don’t know it. The problem is particularly acute in the Washington, DC metropolitan area, where more than 700,000 people are affected, nearly 7,000 patients are on dialysis and more than 1,700 people are waiting for a life-saving kidney transplant. The National Kidney Foundation’s community-based initiative to educate about the kidneys, KEEP Healthy, aims to reduce those numbers by teaching participants to identify Read More >
In case you missed it, the Fort Worth Star-Telegram ran an op-ed by Thomas P. Stossel, American Cancer Society Professor of Medicine at Harvard and a visiting scholar of the American Enterprise Institute, discussing the Democratic Presidential Candidates plans for drug pricing controls and the adverse impact they will have on patients. Read more in the Star-Telegram.